Isracann Biosciences Inc. Share Price

Equities

IPOT

CA46501D1087

Pharmaceuticals

Market Closed - Canadian Securities Exchange 15:41:13 05/04/2023 BST 5-day change 1st Jan Change
0.015 CAD -.--% Intraday chart for Isracann Biosciences Inc. -.--% -.--%

Financials

Sales 2021 - Sales 2022 - Capitalization 11.08M 15.14M 882M
Net income 2021 -25M -34.16M -1.99B Net income 2022 -4M -5.47M -319M EV / Sales 2021 -
Net cash position 2021 1.96M 2.68M 156M Net cash position 2022 214K 292K 17.04M EV / Sales 2022 -
P/E ratio 2021
-1.21 x
P/E ratio 2022
-2.2 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 99.83%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0
0.30
5 years
0.00
Extreme 0
0.68
10 years
0.00
Extreme 0
0.68
More quotes
Managers TitleAgeSince
Chief Executive Officer - 19/01/23
Director of Finance/CFO 42 14/11/17
Chief Tech/Sci/R&D Officer 44 03/06/20
Members of the board TitleAgeSince
Director/Board Member 52 04/07/19
Director/Board Member 34 18/12/17
Director of Finance/CFO 42 14/11/17
More insiders
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.
More about the company